secwatch / observer
8-K filed August 13, 2021, 7:59 PM ET ticker HYPR CIK 0001833769
leadership confidence high sentiment neutral materiality 0.60

HealthCor Catalio CEO Christopher Gaulin resigns; Art Cohen appointed CEO and director

Hyperfine, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christopher Gaulin

Chief Executive Officer and director
HYPR · Hyperfine, Inc.
Effective
2021-08-11
Successor
Art Cohen
Filed
August 13, 2021, 7:59 PM ET
On August 11, 2021, Mr. Christopher Gaulin resigned as Chief Executive Officer and a director of HealthCor Catalio Acquisition Corp., a Cayman Islands exempted company (the “Company”).
Departed

Avi Horev

director
HYPR · Hyperfine, Inc.
Effective
2021-08-11
Successor
Benjamin Snedeker
Filed
August 13, 2021, 7:59 PM ET
Additionally, on August 11, 2021, Mr. Avi Horev resigned as a director of the Company.
Appointed

Art Cohen

Chief Executive Officer and director
HYPR · Hyperfine, Inc.
Effective
2021-08-11
Filed
August 13, 2021, 7:59 PM ET
On August 11, 2021, the board of directors of the Company (the “Board”) appointed Mr. Art Cohen to serve as the Chief Executive Officer of the Company and as a director, effective immediately.
Appointed

Benjamin Snedeker

director
HYPR · Hyperfine, Inc.
Effective
2021-08-11
Filed
August 13, 2021, 7:59 PM ET
On August 11, 2021, the Board appointed Mr. Benjamin Snedeker, age 45, to serve as a director on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Gaulin resigned as Chief Executive Officer and director at Hyperfine, Inc..

Action
resigned
Role
Chief Executive Officer and director
Exact text from the filing
On August 11, 2021, Mr. Christopher Gaulin resigned as Chief Executive Officer and a director of HealthCor Catalio Acquisition Corp., a Cayman Islands exempted company (the “Company”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Avi Horev resigned as director at Hyperfine, Inc..

Action
resigned
Role
director
Exact text from the filing
Additionally, on August 11, 2021, Mr. Avi Horev resigned as a director of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Art Cohen was appointed as Chief Executive Officer and director at Hyperfine, Inc..

Action
appointed
Role
Chief Executive Officer and director
Exact text from the filing
On August 11, 2021, the board of directors of the Company (the “Board”) appointed Mr. Art Cohen to serve as the Chief Executive Officer of the Company and as a director, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Benjamin Snedeker was appointed as director at Hyperfine, Inc..

Action
appointed
Role
director
Exact text from the filing
On August 11, 2021, the Board appointed Mr. Benjamin Snedeker, age 45, to serve as a director on the Board.
View on SEC.gov

Hyperfine, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-21-105103
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.